• Home
  • Our Offerings
  • Rheumatology



Rheumatic diseases often affect one’s joints tendons, ligaments, bones, and muscles. Among them are many types of arthritis, a term used for conditions that affect the joints.

Sometimes they’re referred as musculoskeletal diseases and common symptoms include:

  • • Joint pain
  • • Loss of motion in a joint or joints
  • • Inflammation -- swelling, redness, and warmth in a joint or affected area

Common Rheumatic Disorders

There are more than 200 rheumatic disorders but most common of them are as follows -

  • Osteoarthritis

  • Rheumatoid arthritis (RA)

  • Lupus

  • Spondyloarthropathies – Ankylosing spondylitis (AS) and psoriatic arthritis (PsA)

  • Gout

  • Sjogren’s syndrome

  • Scleroderma

  • Infectious arthritis

  • Juvenile idiopathic arthritis

Diagnosis: Inflammatory diseases often require medical diagnosis to help spot signs and symptoms of the disease which can include eye test, X ray, MRI.

Blood tests can show signs of inflammation including • Erythrocyte sedimentation rate • C-reactive protein • Complete blood count • HLA-B27

Inflammatory diseases can’t be cured, but a qualified clinician can initiate the right treatment after diagnosis of the disease. Inflammatory diseases are completely treatable if your clinician initiates early treatment.

Alkem has taken the following initiatives to ensure enhanced care of RA patients: To raise social awareness on inflammatory diseases with the help of various patient educational media- patient education leaflets, posters, newspaper articles, and patient educational meets.

For disease diagnosis and prevention

To pin down the disease at an early stage, Alkem organizes various detection camps

For stopping the disease progression – Alkem entered the biosimilar segment and introduced brands like MABVINRA injection (Adalimumab) for patients with immunomodulatory diseases, 1st time in India JAK inhibitor TOFE (Tofacitinib 5mg) oral tablets, and Denu (Denosumab 60mg/ml Injection) for subcutaneous use once in 6 months.

Today, with the help of strategic initiatives, Alkem is continuously innovating and working in the direction of inflammatory disease awareness, its diagnosis, and management